TEVA PHARMACEUTICAL INDS LTD's ticker is and the CUSIP is 881624959. A total of 5 filers reported holding TEVA PHARMACEUTICAL INDS LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,579 | +4.1% | 1,135,200 | -23.1% | 0.01% | 0.0% |
Q2 2023 | $11,120 | -26.6% | 1,476,800 | -13.7% | 0.01% | -30.8% |
Q1 2023 | $15,150 | +16.5% | 1,711,900 | +20.0% | 0.01% | -7.1% |
Q4 2022 | $13,007 | -99.9% | 1,426,300 | +24.0% | 0.01% | +40.0% |
Q3 2022 | $9,280,000 | -5.3% | 1,150,000 | -11.8% | 0.01% | 0.0% |
Q2 2022 | $9,804,000 | -30.0% | 1,303,800 | -12.5% | 0.01% | -23.1% |
Q1 2022 | $13,997,000 | +40.4% | 1,490,700 | +19.7% | 0.01% | +30.0% |
Q4 2021 | $9,972,000 | +82.2% | 1,245,000 | +125.7% | 0.01% | +100.0% |
Q3 2021 | $5,472,000 | -0.5% | 551,700 | -0.7% | 0.01% | 0.0% |
Q2 2021 | $5,502,000 | -7.9% | 555,800 | +10629.7% | 0.01% | -54.5% |
Q1 2021 | $5,977,000 | +1.2% | 5,180 | -15.4% | 0.01% | +37.5% |
Q4 2020 | $5,909,000 | -23.3% | 6,124 | -28.4% | 0.01% | -20.0% |
Q3 2020 | $7,701,000 | -40.2% | 8,548 | -18.2% | 0.01% | -52.4% |
Q2 2020 | $12,884,000 | +23.5% | 10,450 | -10.1% | 0.02% | +16.7% |
Q1 2020 | $10,434,000 | +22.3% | 11,620 | +33.5% | 0.02% | -5.3% |
Q4 2019 | $8,531,000 | +49.3% | 8,706 | +4.8% | 0.02% | +18.8% |
Q3 2019 | $5,714,000 | +14.0% | 8,306 | +52.9% | 0.02% | +14.3% |
Q2 2019 | $5,014,000 | +26.4% | 5,433 | +114.7% | 0.01% | +27.3% |
Q1 2019 | $3,967,000 | -69.1% | 2,530 | -69.6% | 0.01% | -71.1% |
Q4 2018 | $12,851,000 | +27.3% | 8,334 | +77.8% | 0.04% | +18.8% |
Q3 2018 | $10,095,000 | +79.4% | 4,687 | +102.5% | 0.03% | +45.5% |
Q2 2018 | $5,627,000 | +597.3% | 2,314 | -17.2% | 0.02% | -37.1% |
Q1 2018 | $807,000 | +40.1% | 2,794 | -1.2% | 0.04% | +40.0% |
Q4 2017 | $576,000 | -82.6% | 2,827 | -27.6% | 0.02% | -81.5% |
Q3 2017 | $3,317,000 | +259.8% | 3,905 | +13.0% | 0.14% | +237.5% |
Q2 2017 | $922,000 | -40.5% | 3,456 | -40.6% | 0.04% | -40.3% |
Q1 2017 | $1,550,000 | +46.4% | 5,819 | +160.2% | 0.07% | +6.3% |
Q4 2016 | $1,059,000 | -27.4% | 2,236 | -18.3% | 0.06% | -36.4% |
Q3 2016 | $1,459,000 | +75.4% | 2,736 | +28.6% | 0.10% | +76.8% |
Q2 2016 | $832,000 | +238.2% | 2,128 | +105.2% | 0.06% | +180.0% |
Q1 2016 | $246,000 | +51.9% | 1,037 | +17.0% | 0.02% | +53.8% |
Q4 2015 | $162,000 | -84.8% | 886 | -35.3% | 0.01% | -83.3% |
Q3 2015 | $1,068,000 | +105.8% | 1,369 | +35.7% | 0.08% | +81.4% |
Q2 2015 | $519,000 | +959.2% | 1,009 | +81.5% | 0.04% | +616.7% |
Q1 2015 | $49,000 | -52.9% | 556 | -48.5% | 0.01% | -53.8% |
Q4 2014 | $104,000 | – | 1,080 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Capital Markets Trading UK LLP | 2,245,200 | $21,082,000 | 0.30% |
GROUP ONE TRADING, L.P. | 4,396,500 | $41,283,000 | 0.04% |
SIMPLEX TRADING, LLC | 1,490,700 | $13,997,000 | 0.01% |
IMC-Chicago, LLC | 439,500 | $4,127,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |